News 
Market Data 
Discover
NWBO CTIX SNTA SBFM THLD PCYC IMUC CUR ISCO
biomanbaba
NWBO CTIX SNTA SBFM THLD PCYC IMUC CUR ISCO
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
NWBO CTIX SNTA SBFM THLD PCYC IMUC CUR ISCO
| Ticker | Board | News | Price | Change | Chg% | Added | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| ARWR | Arrowhead Research Corp | 24.27 | 0.35 | 1.46% | 08/05/2013 | |||||
|
My ARWR Pitch: Cure for Hepatitus could produce explosive returns. Headed to the clinc now as Phase I underway....procrastination causes you to pay up later
|
||||||||||
| ISCO | International Stem Cell Corp. | 0.0712 | 0.0 | 0.00% | 08/05/2013 | |||||
|
My ISCO Pitch: This company is on the frontier of science. Go read every post on that board by KarinCA and myself. If you are not prepared to perform extreme due diligence you dont belong. Consider a full service broker. The stock is Her number one pick and member of my portfolio called Cell Biology Seven
|
||||||||||
| HENC | Hero Technologies Inc | 0.003 | -0.0017 | -36.17% | 03/12/2013 | |||||
|
My HENC Pitch: Best Oil speculation I have seen in years
|
||||||||||
| IPIX | Innovation Pharmaceuticals Inc | 0.0035 | -0.0007 | -16.67% | 08/01/2012 | |||||
|
My IPIX Pitch: Market cap 59 million...are you kidding me...ought to be 100x that
|
||||||||||
| SNTA | Synta Pharmaceuticals Corp. | 02/27/2012 | ||||||||
| IMUC | EOM Pharmaceutical Holdings Inc. | 0.1979 | 0.0 | 0.00% | 02/27/2012 | |||||
| SBFM | Sunshine Biopharma Inc | 1.235 | -0.205 | -14.24% | 02/27/2012 | |||||
|
My SBFM Pitch: results showed that Adva-27a is 16-times more effective at killing multidrug resistant breast cancer cells than Etoposide, a current commonly used drug. In addition, data generated by the study revealed that Adva-27a is unaffected by the molecular machinery which are responsible for making cancer ce
|
||||||||||
| MTEM | Molecular Templates Inc | 1.53 | 0.03 | 2.00% | 01/26/2011 | |||||
|
My MTEM Pitch: their tech will change Cancer therapy in a Massive way
http://www.thresholdpharm.com/ see the video |
||||||||||
